Soterix Medical
Clinical trials sponsored by Soterix Medical, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New device combines brain zaps and mindfulness to fight depression Results expected Sep 2026 (estimated)
-
Precision brain zapping: new hope for stubborn depression?
Symptom relief Not yet recruitingThis study tests a new method of delivering repetitive transcranial magnetic stimulation (rTMS) for people with treatment-resistant depression. Instead of the standard approach, the new method uses brain surface mapping to target a specific area. The trial will compare the two me…
Phase 2 • Sponsor: Soterix Medical • Aim: Symptom relief
Last updated Jun 27, 2026 08:05 UTC
-
Brain scans could reveal how ketamine fights depression
Knowledge-focused Not yet recruitingThis study aims to develop a brain wave (EEG) test that can measure how ketamine affects depression symptoms. Researchers will give ketamine infusions to 20 adults with treatment-resistant depression and track changes in their mood and brain signals. The goal is to find a reliabl…
Phase 1 • Sponsor: Soterix Medical • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC